Ibrutinib outperforms FCR in CLL

Nature Reviews Clinical Oncology, Published online: 15 August 2019; doi:10.1038/s41571-019-0265-6Ibrutinib outperforms FCR in CLL

Source: Nature Reviews Clinical Oncology - August 14, 2019 Category: Cancer & Oncology Authors: Diana Romero Source Type: research